Genmab A/S

Genmab A/S

Sector: Medicinal Chemicals And Botanical Products Region: Denmark

: | NASDAQ OMX Copenhagen: GEN | OTC Markets: GNMSF | OTC Markets: GMXAY | Frankfurt Stock Exchange: GE9

Similar to: SkyePharma Plc, Cyanotech Corp.

Genmab A/S is an international biotechnology company, which specializes in the creation and development of differentiated human antibody therapeutics for the treatment of cancer. The company focuses on product development which creates a portfolio of quality therapeutic products such as Daratumumab and Ofatumumab. It offers partnership and licensing opportunities to develop new products and antibody technologies. Genmab was founded by Lisa N. Drakeman and Jan G. J. van de Winkel in 1999 and is headquartered in Copenhagen, Denmark.

News & Analysis

You may also be interested in: